CN114470138A - Female private part nursing composition and preparation method thereof - Google Patents
Female private part nursing composition and preparation method thereof Download PDFInfo
- Publication number
- CN114470138A CN114470138A CN202210227494.1A CN202210227494A CN114470138A CN 114470138 A CN114470138 A CN 114470138A CN 202210227494 A CN202210227494 A CN 202210227494A CN 114470138 A CN114470138 A CN 114470138A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- main body
- traditional chinese
- medicine containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/007—Injectors for solid bodies, e.g. suppositories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a female private part nursing composition and a preparation method thereof, and relates to the technical field of female maintenance and beauty. The female private part nursing composition comprises a medicine insertion tube and nursing medicines: the medicine insertion tube comprises a medicine containing tube main body, the medicine containing tube main body is arranged in a conical shape, the medicine containing tube main body is arranged in a hollow shape, a plurality of medicine effect diffusion holes which are uniformly distributed are formed in the surface position of the medicine containing tube main body in a penetrating mode, a sealed stirring base is in threaded connection with the bottom surface position of the medicine containing tube main body, and medicine absorption cotton is filled in the inner wall of the medicine containing tube main body and the medicine effect diffusion holes. The pure traditional Chinese medicine formula disclosed by the invention has no side effect on the body of a woman, is more comprehensive in nursing the private parts of the woman, and is suitable for women of all ages.
Description
Technical Field
The invention relates to the technical field of female maintenance and beauty, in particular to a female private part nursing composition and a preparation method thereof.
Background
The vagina is a muscular duct composed of mucosa, a muscular layer and an adventitia, is rich in extensibility, connects the uterus and external genitalia, belongs to female internal genitalia organs, is a female sexual organ, and is also a duct for discharging menstrual blood and delivering a fetus.
The tension of uterus is little before women's parenting, and contractility is low, causes to be pregnant difficult, and some women's menoxenia, and menstrual blood can not flow out, causes the blood clot solidification, leads to situations such as menstrual blood jam, dysmenorrhoea, influences women's endocrine even, and can appear the problem of vagina drier along with women's increase of age, can not wet under simple stinging, seriously influences couple's sexual life.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides a female private part nursing composition and a preparation method thereof, and solves the problems of irregular menstruation, dysmenorrhea, vaginal dryness, difficult conception and the like of women.
(II) technical scheme
In order to achieve the purpose, the invention is realized by the following technical scheme: a female intimate care composition comprising a drug insertion tube and a care drug:
the medicine insertion tube comprises a medicine containing tube main body, the medicine containing tube main body is arranged in a conical shape, the medicine containing tube main body is arranged in a hollow shape, a plurality of medicine effect diffusion holes which are uniformly distributed are formed in the surface position of the medicine containing tube main body in a penetrating mode, a sealed stirring base is in threaded connection with the bottom surface position of the medicine containing tube main body, and medicine absorption cotton is filled in the inner wall of the medicine containing tube main body and the medicine effect diffusion holes;
the nursing medicine is prepared by weighing the following traditional Chinese medicine raw materials in parts by weight: 10-15 parts of radix scrophulariae, 30-35 parts of radix pseudostellariae, 15-18 parts of radix ophiopogonis, 12-15 parts of radix glycyrrhizae preparata, 15-18 parts of wild lily, 8-10 parts of motherwort, 6-8 parts of thunberg fritillary bulb, 10-12 parts of red paeony root, 6-8 parts of ligusticum wallichii, 15-20 parts of salvia miltiorrhiza, 6-8 parts of cortex moutan, 10-12 parts of radix curcumae, 15-18 parts of raw astragalus membranaceus, 10-12 parts of mistletoe, 10-12 parts of pummelo peel, 22-25 parts of sodium alginate and 520 parts of clear water.
Preferably, pesticide residue detection is required to be carried out on the traditional Chinese medicine raw materials of the nursing medicine before use, and the detection standard is in the protection range of the medicinal material pesticide residue determination standard in Chinese pharmacopoeia.
The preparation method of the female private part care composition comprises the following specific steps:
step one, carrying out pesticide detection on the traditional Chinese medicinal materials, taking and cleaning the good-quality and healthy traditional Chinese medicinal materials according to a ratio, and drying after cleaning;
step two, cleaning and drying the heterophylly falsestarwort root, the dwarf lilyturf tuber, the prepared liquorice, the wild lily bulb, the motherwort herb, the thunberg fritillary bulb, the red paeony root, the Szechuan lovage rhizome, the red-rooted salvia root, the tree peony bark, the turmeric root-tuber, the raw astragalus root, the mistletoe and the pummelo peel, putting the mixture into a high-pressure furnace, adding clear water into the high-pressure furnace, pressurizing the mixture to 55-58Mpa at the temperature of 70-75 ℃, and decocting the mixture for 4-5 hours;
step three, cooling the traditional Chinese medicine liquid decocted in the step two to room temperature, filtering the traditional Chinese medicine liquid through a filter to obtain residue-free traditional Chinese medicine liquid, heating the residue-free traditional Chinese medicine liquid to 35-40 ℃, adding sodium alginate, and stirring the residue-free traditional Chinese medicine liquid to fully dissolve the sodium alginate so that the residue-free traditional Chinese medicine liquid becomes a viscous finished product ointment;
and step four, packaging the finished product ointment in a transparent bag by a thermoplastic technology, fixing the transparent bag at the central position of the sealed stirring base close to one side of the medicine containing barrel main body, and carrying out vacuum packaging on the medicine insertion tube through the packaging bag.
Preferably, the method of using the intimate care composition is as follows:
injecting physiological saline into the vagina through a vagina cleaner before use, repeatedly cleaning the vagina, and wiping water stains at the position of the vaginal orifice through sterile gauze;
screwing out the sealing shifting base to take out the packaged finished ointment, tearing the package, extruding the finished ointment into the medicine containing barrel body, and screwing the sealing shifting base at the position of the medicine containing barrel body again to fix the sealing shifting base;
thirdly, slightly shaking the seal to stir the base so that the thick finished ointment in the medicine containing barrel body seeps out of the medicine absorption cotton;
and step four, inserting the medicine containing cylinder main body into the vagina, standing for forty minutes, taking out the medicine containing cylinder main body after forty minutes, and cleaning the vagina through normal saline and a vagina cleaner.
Preferably, in the fourth step, the finished product ointment needs to be sterilized under high pressure before being packaged, the medicine insertion tube needs to be sterilized by ultraviolet rays before being packaged, and the packaging environment of the finished product ointment and the packaging environment of the medicine insertion tube are both sterile environments.
Preferably, the sealed poking base and the medicine containing barrel main body are both made of plastic materials.
(III) advantageous effects
The present invention provides a female intimate care composition and a method of making the same. The method has the following beneficial effects:
the invention can effectively treat and improve irregular menstruation, menstrual blood blockage and menstrual blood non-flow through the heterophylly falsestarwort root, the motherwort herb, the thunberg fritillary bulb, the red paeony root, the szechuan lovage rhizome, the salvia miltiorrhiza bunge, the cortex moutan, the turmeric root-tuber, the raw astragalus root and the mistletoe, has the functions of tonifying qi, invigorating vital energy, invigorating yang, preventing miscarriage and benefiting blood, has the functions of expelling toxin and beautifying, has the functions of nourishing yin and increasing fluid through the dwarf lilyturf tuber, nourishing yin and moistening dryness through the figwort root, ensures that the vagina is wet and smooth, is convenient for sexual intercourse between couples, has the function of stimulating the conception uterus, increases the uterine tension and the uterine contraction, and is convenient for the female to conceive, so the invention has good maintenance effect on female private parts, is practical for women of various ages, has more comprehensive maintenance on the female private parts, and has no side effect on bodies due to pure traditional Chinese medicine formula.
Drawings
FIG. 1 is a schematic view of a drug insertion tube for a female intimate care composition of the invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
as shown in fig. 1, an embodiment of the present invention provides a female intimate care composition comprising a drug insertion tube and a care agent:
the medicine insertion tube comprises a medicine containing tube main body 2, the medicine containing tube main body 2 is arranged in a conical shape, the medicine containing tube main body 2 is arranged in a hollow shape, a plurality of medicine effect diffusion holes 3 which are uniformly distributed penetrate through the surface position of the medicine containing tube main body 2, a sealing shifting base 1 is in threaded connection with the bottom surface position of the medicine containing tube main body 2, medicine absorption cotton is filled in the inner wall of the medicine containing tube main body 2 and the positions of the medicine effect diffusion holes 3, and the sealing shifting base 1 and the medicine containing tube main body 2 are made of plastic materials;
the nursing medicine is prepared by weighing the following traditional Chinese medicine raw materials in parts by weight: 10 parts of radix scrophulariae, 32 parts of radix pseudostellariae, 17 parts of radix ophiopogonis, 14 parts of radix glycyrrhizae preparata, 17 parts of wild lily, 9 parts of motherwort, 7 parts of thunberg fritillary bulb, 11 parts of red peony root, 7 parts of ligusticum wallichii, 19 parts of salvia miltiorrhiza, 15 parts of cortex moutan, 10 parts of radix curcumae, 17 parts of raw astragalus membranaceus, 11 parts of mistletoe, 10 parts of exocarpium citri grandis, 25 parts of sodium alginate and 500 parts of clear water, pesticide residue detection is required before the traditional Chinese medicine raw materials of the nursing medicine are used, and the detection standard is in the protection range of the medicinal material pesticide residue determination standard of the Chinese pharmacopoeia.
The specific method of use of the intimate care composition is as follows:
injecting physiological saline into the vagina through a vagina cleaner before use, repeatedly cleaning the vagina, and wiping water stains at the position of the vaginal orifice through sterile gauze;
screwing out the sealing toggle base 1, taking out the packaged finished ointment, tearing the package, extruding the finished ointment into the medicine containing barrel main body 2, and screwing the sealing toggle base 1 at the position of the medicine containing barrel main body 2 again to fix the sealing toggle base 1;
thirdly, slightly shaking, sealing and stirring the base 1 to enable the thick finished ointment in the medicine containing barrel main body 2 to seep out of the medicine absorption cotton;
and step four, the medicine containing cylinder main body 2 is plugged into the vagina, the medicine containing cylinder main body 2 is kept still for forty minutes, the medicine containing cylinder main body 2 is taken out after forty minutes, the vagina is cleaned through normal saline and a vagina cleaner, and a woman ready for pregnancy can not be used before one month of the ready for pregnancy and during the pregnancy period, so that the phenomenon of miscarriage is avoided.
The preparation method of the female private part care composition comprises the following specific steps:
step one, carrying out pesticide detection on the traditional Chinese medicinal materials, taking and cleaning the good-quality and healthy traditional Chinese medicinal materials according to a ratio, and drying after cleaning;
step two, cleaning and drying the heterophylly falsestarwort root, the dwarf lilyturf tuber, the prepared liquorice, the wild lily bulb, the motherwort herb, the thunberg fritillary bulb, the red paeony root, the Szechuan lovage rhizome, the red-rooted salvia root, the tree peony bark, the turmeric root-tuber, the raw astragalus root, the mistletoe and the pummelo peel, putting the mixture into a high-pressure furnace, adding clear water into the high-pressure furnace, pressurizing the mixture to 55-58Mpa at the temperature of 70-75 ℃, and decocting the mixture for 4-5 hours;
step three, cooling the traditional Chinese medicine liquid decocted in the step two to room temperature, filtering the traditional Chinese medicine liquid through a filter to obtain residue-free traditional Chinese medicine liquid, heating the residue-free traditional Chinese medicine liquid to 35-40 ℃, adding sodium alginate, and stirring the residue-free traditional Chinese medicine liquid to fully dissolve the sodium alginate so that the residue-free traditional Chinese medicine liquid becomes a viscous finished product ointment;
and step four, packaging the finished product ointment in a transparent bag by a thermoplastic technology, fixing the transparent bag at the central position of one side of the sealed stirring base 1 close to the medicine containing barrel main body 2, and carrying out vacuum packaging on the medicine insertion tube through the packaging bag, wherein the finished product ointment needs to be sterilized under high pressure before the finished product ointment is packaged, the medicine insertion tube needs to be sterilized by ultraviolet rays before the finished product ointment is packaged, and the packaging environment of the finished product ointment and the packaging environment of the medicine insertion tube are both sterile environments.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. A female intimate care composition comprising a drug insertion tube and a care agent:
the medicine insertion tube comprises a medicine containing tube main body, the medicine containing tube main body is arranged in a conical shape, the medicine containing tube main body is arranged in a hollow shape, a plurality of medicine effect diffusion holes which are uniformly distributed are formed in the surface position of the medicine containing tube main body in a penetrating mode, a sealed stirring base is in threaded connection with the bottom surface position of the medicine containing tube main body, and medicine absorption cotton is filled in the inner wall of the medicine containing tube main body and the medicine effect diffusion holes;
the nursing medicine is prepared by weighing the following traditional Chinese medicine raw materials in parts by weight: 10-15 parts of radix scrophulariae, 30-35 parts of radix pseudostellariae, 15-18 parts of radix ophiopogonis, 12-15 parts of radix glycyrrhizae preparata, 15-18 parts of wild lily, 8-10 parts of motherwort, 6-8 parts of thunberg fritillary bulb, 10-12 parts of red paeony root, 6-8 parts of ligusticum wallichii, 15-20 parts of salvia miltiorrhiza, 6-8 parts of cortex moutan, 10-12 parts of radix curcumae, 15-18 parts of raw astragalus membranaceus, 10-12 parts of parasitic loranthus, 10-12 parts of pummelo peel, 22-25 parts of sodium alginate and 520 parts of clear water.
2. The female private part nursing composition according to claim 1, wherein the traditional Chinese medicine raw materials of the nursing medicine need to be tested for pesticide residues before use, and the testing standard is in the protection range of the testing standard of pesticide residues of medicinal materials in the Chinese pharmacopoeia.
3. The preparation method of the female private part care composition is characterized by comprising the following steps:
step one, carrying out pesticide detection on the traditional Chinese medicinal materials, taking and cleaning the good-quality and healthy traditional Chinese medicinal materials according to a ratio, and drying after cleaning;
step two, cleaning and drying the heterophylly falsestarwort root, the dwarf lilyturf tuber, the prepared liquorice, the wild lily bulb, the motherwort herb, the thunberg fritillary bulb, the red paeony root, the Szechuan lovage rhizome, the red-rooted salvia root, the tree peony bark, the turmeric root-tuber, the raw astragalus root, the mistletoe and the pummelo peel, putting the mixture into a high-pressure furnace, adding clear water into the high-pressure furnace, pressurizing the mixture to 55-58Mpa at the temperature of 70-75 ℃, and decocting the mixture for 4-5 hours;
step three, cooling the traditional Chinese medicine liquid decocted in the step two to room temperature, filtering the traditional Chinese medicine liquid through a filter to obtain residue-free traditional Chinese medicine liquid, heating the residue-free traditional Chinese medicine liquid to 35-40 ℃, adding sodium alginate, and stirring the residue-free traditional Chinese medicine liquid to fully dissolve the sodium alginate so that the residue-free traditional Chinese medicine liquid becomes a viscous finished product ointment;
and step four, packaging the finished product ointment in a transparent bag by a thermoplastic technology, fixing the transparent bag at the central position of the sealed stirring base close to one side of the medicine containing barrel main body, and carrying out vacuum packaging on the medicine insertion tube through the packaging bag.
4. A female intimate care composition according to claim 1, wherein said intimate care composition is used in the following specific manner:
injecting physiological saline into the vagina through a vagina cleaner before use, repeatedly cleaning the vagina, and wiping water stains at the position of the vaginal orifice through sterile gauze;
screwing out the sealing shifting base to take out the packaged finished ointment, tearing the package, extruding the finished ointment into the medicine containing barrel body, and screwing the sealing shifting base at the position of the medicine containing barrel body again to fix the sealing shifting base;
thirdly, slightly shaking the seal to stir the base so that the thick finished ointment in the medicine containing barrel body seeps out of the medicine absorption cotton;
and step four, inserting the medicine containing cylinder main body into the vagina, standing for forty minutes, taking out the medicine containing cylinder main body after forty minutes, and cleaning the vagina through normal saline and a vagina cleaner.
5. The method for preparing a female intimate care composition as claimed in claim 3, wherein in step four, the finished ointment is autoclaved before being packaged, the drug insertion tube is sterilized by ultraviolet rays before being packaged, and the packaging environment of the finished ointment and the packaging environment of the drug insertion tube are both aseptic environment.
6. The female intimate care composition of claim 1 wherein said sealed dial base and said cartridge body are both plastic materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210227494.1A CN114470138A (en) | 2022-03-08 | 2022-03-08 | Female private part nursing composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210227494.1A CN114470138A (en) | 2022-03-08 | 2022-03-08 | Female private part nursing composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114470138A true CN114470138A (en) | 2022-05-13 |
Family
ID=81486350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210227494.1A Withdrawn CN114470138A (en) | 2022-03-08 | 2022-03-08 | Female private part nursing composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114470138A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1486705A (en) * | 2002-08-04 | 2004-04-07 | 秦瑞琳 | Menstruation regulating and pregnancy promoting capsule and its prepn |
| CN201930397U (en) * | 2011-02-08 | 2011-08-17 | 郑延芳 | Disposable vagina drug administration device |
| CN108904692A (en) * | 2018-10-16 | 2018-11-30 | 苗怡文 | A method of preparing the Chinese medicine composition for the treatment of menopausal syndrome |
| CN109350652A (en) * | 2018-05-25 | 2019-02-19 | 泓博元生命科技（深圳）有限公司 | The composition of improvement menopause symptom containing NADH, preparation and the preparation method and application thereof |
-
2022
- 2022-03-08 CN CN202210227494.1A patent/CN114470138A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1486705A (en) * | 2002-08-04 | 2004-04-07 | 秦瑞琳 | Menstruation regulating and pregnancy promoting capsule and its prepn |
| CN201930397U (en) * | 2011-02-08 | 2011-08-17 | 郑延芳 | Disposable vagina drug administration device |
| CN109350652A (en) * | 2018-05-25 | 2019-02-19 | 泓博元生命科技（深圳）有限公司 | The composition of improvement menopause symptom containing NADH, preparation and the preparation method and application thereof |
| CN108904692A (en) * | 2018-10-16 | 2018-11-30 | 苗怡文 | A method of preparing the Chinese medicine composition for the treatment of menopausal syndrome |
Non-Patent Citations (1)
| Title |
|---|
| 陈凤仁 等: "集灵方加减治愈妇科阴中干涩症" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272144B (en) | Medicine for treating polycystic ovarian syndrome | |
| CN102462827A (en) | Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat | |
| CN103071105B (en) | External traditional Chinese medicinal preparation for treating threatened abortion and preparation method thereof | |
| CN105770424A (en) | Medicine for treating dead spermia and preparation thereof | |
| CN114470138A (en) | Female private part nursing composition and preparation method thereof | |
| CN111053827A (en) | External traditional Chinese medicine for contracting vagina and treating gynecological inflammation and preparation method thereof | |
| CN104587127A (en) | Traditional Chinese medicine preparation for treating dysfunctional uterine bleeding and preparation method thereof | |
| CN103071096B (en) | External preparation for treating senile vaginitis and preparation method of external preparation | |
| CN103301415B (en) | Medicinal composition for preventing and treating intrauterine adhesion after induced abortion operation and application thereof | |
| CN101129948B (en) | Pharmaceutical composition for treating gynecology hysteromyoma and processes for producing same | |
| CN102579786B (en) | Traditional Chinese medicine for treating nonliquefaction of semen | |
| CN101637599B (en) | Chinese medicinal composition for removing haemostasis in female genital system | |
| CN104547396A (en) | Traditional Chinese medicinal composition for treating delayed menstrual cycle | |
| CN103494918B (en) | Ginseng and astragalus yang-warming vaginal dilation suppository as well as preparation method and detection method thereof | |
| CN102389557B (en) | Chinese medicinal composition and Chinese medicinal ball for treating uterine cancer and application thereof | |
| CN104173981A (en) | Medical decoction for treating uterine fibroids and hypertrophy of uterus and preparation method thereof | |
| CN103285367A (en) | Traditional Chinese medicine composition for bleeding after drug abortion | |
| CN103110722B (en) | Traditional Chinese medicine for treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN103182054A (en) | Traditional Chinese medicine composition used for treating immune infertility, and preparation method and application thereof | |
| CN102526590B (en) | Chinese medicament for improving IVF-ET post-implantation dysfunction | |
| CN102716249A (en) | Medicinal composition for treating hyperplasia of prostate and preparation method thereof | |
| CN208660124U (en) | A kind of gynemetrics's drug delivery device | |
| CN104491622A (en) | Pharmaceutical composition for treating delayed menstrual cycle | |
| CN105311396A (en) | Traditional Chinese medicine preparation for treating hypomenorrhea caused by thin endometrium | |
| CN101264285A (en) | Chinese medicine assembly for treating cervical cancer and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220513 |